Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lifeward Ltd.RWLK · Entity 7620 | Chief Financial Officer | June 30, 2021 | July 01, 2021 |
| REGENTIS BIOMATERIALS LTD.RGNT · Entity 7824 | Chief Financial Officer | March 18, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lifeward Ltd.
Report date June 30, 2021 · Filed July 01, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 0.25 per shareSEC Table I · non-derivative | IndirectESOP | 241,282 |
Reported balance
After 2021-06-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2021-06-30 · Grant · Acquired 75,000 · Balance 241,282 F1: Represents 75,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 30, 2021, under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly instalments starting on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 75,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 30, 2021, under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly instalments starting on the first anniversary of the date of grant.
REGENTIS BIOMATERIALS LTD.
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.00 · Expires 2037-02-23 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: This option was granted on February 23, 2026. The options shall vest on a quarterly basis, with one-sixth (1/6) of the options vesting upon the six-month anniversary of the grant date and one-twelfth (1/12) vesting on the last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted on February 23, 2026. The options shall vest on a quarterly basis, with one-sixth (1/6) of the options vesting upon the six-month anniversary of the grant date and one-twelfth (1/12) vesting on the last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2021 Filed Jul 1, 2021 12:34 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-002195 · zk2126252.xml · nonDerivative · entry 1 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 241,282 F1 · shares: Represents 75,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 30, 2021, under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly instalments starting on the first anniversary of the date of grant. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 20:57 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001985 · zk2024651.xml · nonDerivative · entry 2 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 16,282 F2 · shares: Represents 10,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest immediately on the date of grant. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 20:57 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001985 · zk2024651.xml · nonDerivative · entry 1 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 166,282 F1 · shares: Represents 150,000 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly instalments starting on the first anniversary of the date of grant. Read SEC document |
| June 01, 2019 Filed Jun 6, 2019 20:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-010197 · doc4.xml · nonDerivative · entry 1 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 6,282 F1 · shares: Represents 4,500 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on June 1, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in three equal yearly installments starting on the first anniversary of the date of grant. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:52 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 65,625 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001607962-18-000028 · wf-form4_152572269287248.xml · derivative · entry 2 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,625 Underlying: Option (Right to buy) · 65,625 shares Expires 2028-05-03 F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on May 3, 2018. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. Read SEC document |
| May 03, 2018 Filed May 7, 2018 19:52 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 13,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001607962-18-000028 · wf-form4_152572269287248.xml · nonDerivative · entry 1 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 44,567 F1 · shares: Represents 13,125 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 3, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal yearly installments starting on the first anniversary of the date of grant. Read SEC document |
| February 22, 2018 Filed Mar 6, 2018 21:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (right to buy) · Derivative | 96,525 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001213900-18-002616 · f4022218gon_rewalkrobotics.xml · derivative · entry 2 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,525 Underlying: Ordinary Shares, par value 0.01 NIS per share · 96,525 shares Expires 2028-02-22 F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on February 22, 2018 in connection with the reporting person's appointment as Chief Financial Officer effective as of that date. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. Read SEC document |
| February 22, 2018 Filed Mar 6, 2018 21:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary shares, par value NIS 0.01 per share | 17,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-18-002616 · f4022218gon_rewalkrobotics.xml · nonDerivative · entry 1 Gon Ori · CIK 0001732525 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 31,442 F1 · shares: Represents 17,857 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on February 22, 2018 in connection with the reporting person's appointment as Chief Financial Officer effective as of that date. The RSUs vest in four equal annual installments starting on the first anniversary of the date of grant, and may only be settled in Ordinary Shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.